Polaryx Therapeutics, Inc. PLYX Balance Sheet Statement
| FY'25 | FY'24 | ||
|---|---|---|---|
| $5.14M+11.3% | $4.62M— | ||
| $5.17M+3.4% | $5M— | ||
| $5.17M+3.4% | $5M— | ||
| —— | -$228.75K— | ||
| $605K+109% | $289K— | ||
| $605K+109% | $289K— | ||
| $560M0.0% | $560M— | ||
| -$99.64M-9.9% | -$90.65M— | ||
| $4.57M-3.1% | $4.71M+269% | ||
| $5.17M+3.4% | $5M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Polaryx Therapeutics, Inc. 's total assets?
- Polaryx Therapeutics, Inc. (PLYX) holds $3.5M in total assets.
- How much cash does Polaryx Therapeutics, Inc. have?
- Polaryx Therapeutics, Inc. holds $3.1M in cash and equivalents.
- Can Polaryx Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 3.45 — current assets exceed current liabilities.
- Where does Polaryx Therapeutics, Inc. 's balance sheet data come from?
- Every line is extracted from Polaryx Therapeutics, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.